NeuroNasal

🍄 Psychedelics· 📍 San Diego, CA, USA

Overview

Specialty pharmaceutical company developing intranasal delivery formulations of psychedelic compounds including psilocybin and ketamine for rapid onset psychiatric treatment. Their proprietary nasal delivery technology improves bioavailability and dose precision.

More in Psychedelics

Algernon Pharmaceuticals

Vancouver, Canada

Apex Labs

Calgary, Canada

atai Life Sciences

Berlin, Germany

Awakn Europe

Bristol, United Kingdom

Awakn Life Sciences

Bristol, UK

Beckley Foundation

Oxford, United Kingdom

Latest industry news

FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD

2026-09-23 · Policy

Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device

2026-09-22 · Product

Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development

2026-09-21 · Funding

UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology

2026-09-20 · Funding

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →